Experience in the use of Mexidol® in children and adolescents with mental disorders

Authors:
Yu.Sh. Vasyanina

Place of publication:
Psychiatry and narcology, 2012

Summary:
Analyzing indicators of pain and incidence of children and adolescents of the Krasnodar Territory, in the class of mental disorders we observe stably high indicators among the child population and steady growth in adolescents. So, as of January 1, 2010, every 33 child and every 20 teenager is observed and treated in psychiatrists. In the nosological structure of mental disorders in children and adolescents of the region, mental disorders of a non-tochitotic nature prevail (69.65%), in 2nd place mental retardation (29.0%), psychoses are 1.35%. In the conditions of outpatient reception of a children's psychiatrist, cognitive and psychosomatic disorders are most common, as well as disorders of anxious-phobic spectrum on a residual-organic background, which is consistent with the data summarized by L.O. Badalyan, N.N. Zavadenko, T.Yu. Uspenskaya. The therapeutic strategies we use in children and adolescents combine psychotherapy and pharmacotherapy. The central link of therapeutic effect is psychocorrection and psychotherapy. Pharmacotherapy in child-teenage age is associated with a number of difficulties: it is difficult to convince parents to contact a psychiatrist and start a long-term medical treatment.